For oral use. Take the solution once daily. It should be taken one hour before or two hours after intake of food or fruit juice. Use the provided measuring device (e.g., syringe or spoon) for accurate dosing. Shake well before use.

Bilastine is a selective histamine H1 receptor antagonist. It binds to H1 receptors, blocking the action of histamine, a chemical mediator released during allergic reactions. This reduces symptoms like itching, sneezing, and watery eyes.

• •Hypersensitivity to Bilastine or any of the excipients
• •Children under 6 years of age (for specific formulations, general guideline for Bilastine)

Store below 30°C. Do not freeze. Keep out of the sight and reach of children. Store in the original package to protect from light.

No serious adverse events were observed after acute overdose (up to 264 mg). Symptoms may include dizziness, headache, and nausea. Management should be symptomatic and supportive, as there is no specific antidote.

Limited data on use in pregnant women. Animal studies do not indicate direct or indirect harmful effects. As a precautionary measure, it is preferable to avoid the use of Bilastine during pregnancy. It is not known whether Bilastine is excreted in human milk. A decision must be made whether to discontinue breastfeeding or to discontinue/abstain from Bilastine therapy taking into account the benefit of breastfeeding for the child and the benefit of therapy for the woman.